Practical guidelines for vancomycin usage, with prospective drug-utilization evaluation

被引：11
|
作者：
Drori-Zeides, T
Raveh, D
Schlesinger, Y
Yinnon, AM
机构：
[1] Shaare Zedek Med Ctr, Infect Dis Unit, IL-91031 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel
来源：
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY | 2000年 / 21卷 / 01期
关键词：
D O I：
10.1086/501697
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
To strengthen guidelines for vancomycin use,practical guidelines were developed. A prospective survey was conducted of all patients receiving vancomycin during two 1-month periods, 1 year apart, during which significant improvements were noted. Practical guidelines may contribute to appropriateness of vancomycin use, serve as educational tools, and facilitate improved surveillance (Infect Control Hosp Epidemiol 2000;21:4547).
引用
收藏
页码：45 / 47
页数：3
相关论文
共 50 条
  • [21] The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance
    Marco Tuccori
    Irma Convertino
    Sara Ferraro
    Emiliano Cappello
    Giulia Valdiserra
    Daniele Focosi
    Corrado Blandizzi
    Drug Safety, 2020, 43 : 699 - 709
  • [22] Drug-utilization study examining characteristics of patients prescribed add-on treatment to metformin
    Carlos Bazo-Alvarez, Juan
    Petersen, Irene
    Nazareth, Irwin
    Sharma, Manuj
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 517 - 517
  • [23] Use of Biological Drugs for Psoriasis: A Drug-utilization Study Using Tuscan Administrative Databanks
    Giometto, S.
    Tillati, S.
    Baglietto, L.
    Bortoli, N. D.
    Mosca, M.
    Conte, M.
    Tuccori, M.
    Gini, R.
    Lucenteforte, E.
    DRUG SAFETY, 2022, 45 (10) : 1152 - 1153
  • [24] Use of Biological Drugs for Psoriasis: A Drug-Utilization Study Using Tuscan Administrative Databanks
    Giometto, Sabrina
    Tillati, Silvia
    Baglietto, Laura
    De Bortoli, Nicola
    Mosca, Marta
    Conte, Marco
    Tuccori, Marco
    Gini, Rosa
    Lucenteforte, Ersilia
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (11)
  • [25] Guidelines for Therapeutic Drug Monitoring of Vancomycin: A Systematic Review
    Ye, Zhi-Kang
    Li, Can
    Zhai, Suo-Di
    PLOS ONE, 2014, 9 (06):
  • [26] THERAPEUTIC DRUG MONITORING OF VANCOMYCIN (TDM-V) IN NEONATES AND PAEDIATRICS: EVALUATION OF GUIDELINES AND RECOMMENDATIONS
    Diaz, L.
    Garcia, I
    Hernandez, R.
    Munoz, M.
    Frias, J.
    Ramirez, E.
    Borobia, A. M.
    Carcas, A. J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 : 33 - 33
  • [27] Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis
    Convertino, Irma
    Lorenzoni, Valentina
    Gini, Rosa
    Turchetti, Giuseppe
    Fini, Elisabetta
    Giometto, Sabrina
    Bartolini, Claudia
    Paoletti, Olga
    Ferraro, Sara
    Cappello, Emiliano
    Valdiserra, Giulia
    Bonaso, Marco
    Blandizzi, Corrado
    Tuccori, Marco
    Lucenteforte, Ersilia
    PHARMACEUTICALS, 2023, 16 (03)
  • [28] Evaluation results from prospective drug utilization review: Medicaid demonstrations
    Kidder, D
    Bae, J
    HEALTH CARE FINANCING REVIEW, 1999, 20 (03): : 107 - 118
  • [29] DRUG UTILIZATION REVIEW IN A TEACHING HOSPITAL - EXPERIENCE WITH VANCOMYCIN
    MISAN, GMH
    MARTIN, ED
    SMITH, ER
    SOMOGYI, AA
    BARTHOLOMEUSZ, RCA
    BOCHNER, F
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (05) : 457 - 461
  • [30] Use of Psychotropic Drugs in Children and Adolescents with Tic Disorders in Denmark: A Nationwide Drug-Utilization Study
    Rasmussen, Lotte
    Thrane, Julie M.
    Bilenberg, Niels
    Pottegard, Anton
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 33 - 33
12345